Search results

Value-based healthcare suggested using patient-reported information to complement the information available in the medical records and administrative healthcare data to provide insights into patients' perceptions of satisfaction, experience and self-reported outcomes. However, little attention has been devoted to questions about factors fostering the use of patient-reported information to create value at the system level.

Action research design is carried out to elicit possible triggers using the case of patient-reported experience and outcome data for breast cancer women along their clinical pathway in the clinical breast network of Tuscany (Italy).

The case shows that communication and engagement of multi-stakeholder representation are needed for making information actionable in a multi-level, multispecialty care pathway organized in a clinical network; moreover, political and managerial support from higher level governance is a stimulus for legitimizing the use for quality improvement. At the organizational level, an external facilitator disclosing and discussing real-world uses of collected data is a trigger to link measures to action. Also, clinical champion(s) and clear goals are key success factors. Nonetheless, resource munificent and dedicated information support tools together with education and learning routines are enabling factors.

Current literature focuses on key factors that impact performance information use often considering unidimensional performance and internal sources of information. The use of patient/user-reported information is not yet well-studied especially in supporting quality improvement in multi-stakeholder governance. The work appears relevant for the implications it carries, especially for policymakers and public sector managers when confronting the gap in patient-reported measures for quality improvement.

COVID-19 has occurred in more than 150 countries and causes a huge impact on the health of many people. The main purpose of this work is, COVID-19 has occurred in more than 150 countries and causes a huge impact on the health of many people. The COVID-19 diagnosis is required to detect at the beginning stage and special attention should be given to them. The fastest way to detect the COVID-19 infected patients is detecting through radiology and radiography images. The few early studies describe the particular abnormalities of the infected patients in the chest radiograms. Even though some of the challenges occur in concluding the viral infection traces in X-ray images, the convolutional neural network (CNN) can determine the patterns of data between the normal and infected X-rays that increase the detection rate. Therefore, the researchers are focusing on developing a deep learning-based detection model.

The main intention of this proposal is to develop the enhanced lung segmentation and classification of diagnosing the COVID-19. The main processes of the proposed model are image pre-processing, lung segmentation and deep classification. Initially, the image enhancement is performed by contrast enhancement and filtering approaches. Once the image is pre-processed, the optimal lung segmentation is done by the adaptive fuzzy-based region growing (AFRG) technique, in which the constant function for fusion is optimized by the modified deer hunting optimization algorithm (M-DHOA). Further, a well-performing deep learning algorithm termed adaptive CNN (A-CNN) is adopted for performing the classification, in which the hidden neurons are tuned by the proposed DHOA to enhance the detection accuracy. The simulation results illustrate that the proposed model has more possibilities to increase the COVID-19 testing methods on the publicly available data sets.

From the experimental analysis, the accuracy of the proposed M-DHOA–CNN was 5.84%, 5.23%, 6.25% and 8.33% superior to recurrent neural network, neural networks, support vector machine and K-nearest neighbor, respectively. Thus, the segmentation and classification performance of the developed COVID-19 diagnosis by AFRG and A-CNN has outperformed the existing techniques.

This paper adopts the latest optimization algorithm called M-DHOA to improve the performance of lung segmentation and classification in COVID-19 diagnosis using adaptive K-means with region growing fusion and A-CNN. To the best of the authors’ knowledge, this is the first work that uses M-DHOA for improved segmentation and classification steps for increasing the convergence rate of diagnosis.

Due to the rapid development of artificial intelligence (AI) technology, increasing the use of AI in healthcare is critical, but few studies have explored the extent to which physicians cooperate with AI in their work to achieve productive and innovative performance, which is a key issue in operations management (OM). We conducted empirical research to answer this question.

We developed a conceptual model based on the ambidextrous perspective. To test our model, we collected data from 200 Chinese hospitals. One senior and one junior physician from each hospital participated in this research so that we could get a more comprehensive view. Based on the sample of 400 participants and the conceptual model, we examined whether different types of AI use have distinct impacts on physicians’ productivity and innovation by conducting hierarchical regression and post hoc tests. We also introduced team psychological safety climate (TPSC) and AI technology uncertainty (AITU) as moderators to investigate this topic in further detail.

We found that augmentation AI use is positively related to overall productivity and innovative job performance, while automation AI use is negatively related to these two outcomes. Furthermore, we focused on the impacts of the ambidextrous use of AI on these two outcomes. The results highlight the positive impacts of complementary use on both outcomes and the negative impact of balance on innovative job performance. TPSC enhances the positive impacts of complementary use on productivity, whereas AITU inhibits the negative impacts of automation and balanced use on innovative job performance.

In the age of AI, organizations face greater trade-offs between performance and technology management. This study contributes to the OM literature from the perspectives of operational performance and technology management in three ways. First, it distinguishes among different AI implementations and their diverse impacts on productivity and innovative performance. Second, it identifies the different conditions under which automation AI use and augmentation are superior. Third, it extends the ambidextrous perspective by becoming an early adopter of this approach to explore the implications of different types of AI use in light of contingency factors.